Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.
And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.
There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:
- Invest mainly in well-established companies;
- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
- Downplay or avoid stocks in the broker/media limelight.
Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.
RTI’s investors will exchange their holdings for Alcoa common shares. If you include RTI’s cash balances and debt, the deal is worth $1.5 billion. Alcoa expects to close it in the next six months.
Alcoa is a buy.
...
Amex also plans to repurchase up to $6.6 billion worth of its stock by June 30, 2016, up 50.0% from $4.4 billion in 2014.
The company’s 2015 earnings will probably fall to $5.49 a share from $5.56 in 2014. However, Amex’s current restructuring plan, which includes a 6% cut to its workforce, could push its earnings up to $6.00 a share in 2016. The stock trades at 13.3 times that estimate.
...
Morgan also plans to buy back up to $6.4 billion worth of its shares by June 30, 2016, compared to the $4.8 billion it spent on repurchases in 2014.
The bank will probably earn $5.79 a share in 2015, up 9.5% from $5.29 in 2014. The stock trades at 10.4 times that estimate.
...
As well, the bank will likely earmark more funds for share buybacks in 2015 than the $9.4 billion it spent last year. That will help push up this year’s projected earnings to $4.16 a share from $4.10 in 2014. The stock trades at 13.2 times that forecast.
Wells Fargo is a buy.
...
In addition, the company makes computers and software that help clinics and pharmacies manage their drug inventories. The technology solutions division accounts for just 2% of McKesson’s revenue but supplies 12% of its earnings.
In February 2014, McKesson acquired 77.6% of Celesio AG, a German firm that distributes prescription drugs in Europe and Brazil. If you include McKesson’s share of Celesio’s cash, it paid $4.5 billion for this stake. Celesio has issued more shares since then, reducing McKesson’s interest to 75.9%.
...
In 2014, Teradata’s earnings fell 1.5%, to $452 million from $459 million in 2013. But per-share earnings rose 3.6%, to $2.86 from $2.76, on fewer shares outstanding. Revenue gained 1.5%, to $2.73 billion from $2.69 billion.
Strong competition from bigger firms, like IBM and Oracle, will likely cut Teradata’s 2015 earnings to $2.60 a share. The stock trades at a somewhat high 16.5 times that forecast.
...
In its fiscal 2015 first quarter, which ended December 27, 2014, MTS’s revenue rose 3.0%, to $142.6 million from $138.4 million a year earlier. Overall earnings improved 14.5%, to $13.8 million from $12.0 million. Earnings per share gained 16.7%, to $0.91 from $0.78, on fewer shares outstanding. MTS spends 4% of its revenue on research.
The higher earnings are partly due to a recent restructuring plan that should cut MTS’s annual costs by $6 million.
...
The company sells its products to industrial clients, including computer chipmakers (43% of total revenue), communications equipment suppliers (34%) and aerospace and defence firms (23%).
In its fiscal 2015 first quarter, which ended January 31, 2015, Keysight’s revenue gained 4.5%, to $701 million from $671 million a year earlier. Without the negative impact of exchange rates, revenue rose 7%.
...
One firm kept the Agilent name and stock symbol and focuses on testing equipment for medical research labs. It gets 70% of its revenue from overseas.
The second company, called Keysight Technologies (see right), makes testing systems for electronics.
...
As part of a new plan to focus on its main operations, ABB sold several small businesses for a total of $1.1 billion in 2014. As well, the company is focusing on power projects with strong potential and turning down risky, less profitable orders. At the same time, a restructuring plan, including plant closures and job cuts, saved the company a further $1.1 billion in 2014.
Partly due to asset sales, ABB’s revenue fell 4.8% in 2014, to $39.8 billion from $41.8 billion in 2013. However, orders for new equipment rose 6.7%, to $41.5 billion from $38.9 billion.
...